Clinical Trial Update: A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled Corticosteroids [Phase 2]

View source ↗

Summary

This clinical trial update indicates the Phase 2 study evaluating Lebrikizumab in adult asthma patients not taking inhaled corticosteroids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED